✅Relating to Medicaid and child health plan program coverage and reimbursement for childhood cranial remolding orthosis.
HB 426
✅ HB 426: Medicaid coverage for infant cranial helmets
What it says it does:
Requires Texas Medicaid and CHIP to cover cranial remolding orthoses for children with specific cranial deformities like plagiocephaly, brachycephaly, or craniosynostosis. Coverage must be no less favorable than other orthotic devices.
What it actually changes:
Adds a new mandatory benefit to Medicaid and CHIP, ensuring that helmet therapy can no longer be denied as “cosmetic” if medical criteria are met. It defines age limits, therapy prerequisites, and measurement thresholds, and lets HHSC delay implementation only if a federal waiver is required.
Who is pushing for it:
Support came from orthotics providers such as Hanger Clinic and Ottobock, hospitals in the Children’s Hospital Association of Texas, the Texas Medical Association, and Methodist Healthcare Ministries. HHSC staff registered “on” the bill.
Who benefits:
Families whose infants need helmet therapy gain coverage for what was often an out-of-pocket cost. Orthotics providers and pediatric hospitals gain predictable reimbursement and steady patient flow.
Who gets left out or exposed:
Families outside Medicaid or CHIP are unaffected. Managed care organizations lose discretion to classify helmets as elective, and HHSC must manage new costs and rulemaking without added resources.
Why this matters long term:
It sets a precedent for defining pediatric coverage by statute rather than agency discretion, strengthening patient rights but also creating ongoing fiscal obligations. It shows how targeted benefit mandates can close medical gaps without major program redesign.
What to watch next:
Implementation timing and rate-setting by HHSC will decide real access. If policy updates lag or rates are too low, coverage may exist on paper but not in practice. Legislative oversight should ensure timelines and adequate funding.
Bottom line:
HB 426 is a family-centered correction to past denials, converting a disputed therapy into a guaranteed benefit. It relies on agency follow-through, not new bureaucracy, and its success will depend on transparent rollout and fair reimbursement.
#HB426 #TexasPolicy #TexasHealthcare #TexasMedicaid #KnowBeforeYouVote